These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 11381201)
1. Linking genotype with phenotype in inflammatory bowel disease--Will we ever have reagent standard patients? Ghosh S Dis Markers; 2000; 16(3-4):167-71. PubMed ID: 11381201 [No Abstract] [Full Text] [Related]
2. [Inflammatory bowel disease: genotype-fenotype relationship]. Gómez de la Concha E An R Acad Nac Med (Madr); 2006; 123(2):307-17; discussion 318-20. PubMed ID: 17310638 [TBL] [Abstract][Full Text] [Related]
3. What is the risk that a child will develop inflammatory bowel disease if 1 or both parents have IBD? Noble CL; Arnott ID Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S22-3. PubMed ID: 18816708 [No Abstract] [Full Text] [Related]
4. Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis. Márquez L; Shen C; Cleynen I; De Hertogh G; Van Steen K; Machiels K; Perrier C; Ballet V; Organe S; Ferrante M; Henckaerts L; Galicia G; Rutgeerts P; Ceuppens JL; Vermeire S Gut; 2012 Apr; 61(4):528-34. PubMed ID: 21708824 [TBL] [Abstract][Full Text] [Related]
5. [Genetics of inflammatory bowel diseases]. Hugot JP; Laurent-Puig P; Thomas G Gastroenterol Clin Biol; 1995 Nov; 19(11):890-8. PubMed ID: 8746047 [No Abstract] [Full Text] [Related]
6. Linkage of ulcerative colitis to the pericentromeric region of chromosome 16 in Italian inflammatory bowel disease families is independent of the presence of common CARD15 mutations. Annese V; Latiano A; Palmieri O; Li HH; Forabosco P; Ferraris A; Andriulli A; Vecchi M; Ardizzone S; Cottone M; Dallapiccola B; Rappaport E; Fortina P; Devoto M J Med Genet; 2003 Nov; 40(11):837-41. PubMed ID: 14627676 [No Abstract] [Full Text] [Related]
8. Inflammatory bowel disease: Are there gender differences in the genetics of signal transduction? A preliminary study of cytosolic low molecular weight protein tyrosine phosphatase. Bottini N; Gloria-Bottini F; Lucarini N; Ronchetti PG; Fontana L Dis Markers; 2000; 16(3-4):163-6. PubMed ID: 11381200 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology, genes and inflammatory bowel diseases in childhood. de Mesquita MB; Civitelli F; Levine A Dig Liver Dis; 2008 Jan; 40(1):3-11. PubMed ID: 17997369 [TBL] [Abstract][Full Text] [Related]
10. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease. Ozen SC; Dagli U; Kiliç MY; Törüner M; Celik Y; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM J Gastroenterol; 2006 Apr; 41(4):304-10. PubMed ID: 16741608 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease and innate immune response genes: the challenge of complex polygenic disorders for the clinical geneticist. Haigh B Clin Genet; 2006 Apr; 69(4):315-8. PubMed ID: 16630164 [No Abstract] [Full Text] [Related]
12. Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region). Rönnblom A; Holmström T; Tanghöj H; Rorsman F; Sjöberg D J Gastroenterol Hepatol; 2015 Aug; 30(8):1288-92. PubMed ID: 25777994 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology of IBD: genetic versus environmental influences on the etiology of disease. Mack DR J Pediatr Gastroenterol Nutr; 1992 Jan; 14(1):117. PubMed ID: 1573502 [No Abstract] [Full Text] [Related]
14. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India. Mittal RD; Bid HK; Ghoshal UC Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659 [TBL] [Abstract][Full Text] [Related]
15. Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease. Oliver J; Márquez A; Gómez-Garcia M; Martinez A; Mendoza JL; Vilchez JR; López-Nevot MA; Piñero A; de la Concha EG; Nieto A; Urcelay E; Martín J Gut; 2007 Jan; 56(1):150-1. PubMed ID: 17172590 [No Abstract] [Full Text] [Related]
16. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974 [TBL] [Abstract][Full Text] [Related]
17. Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits. Taleban S; Li D; Targan SR; Ippoliti A; Brant SR; Cho JH; Duerr RH; Rioux JD; Silverberg MS; Vasiliauskas EA; Rotter JI; Haritunians T; Shih DQ; Dubinsky M; Melmed GY; McGovern DP J Crohns Colitis; 2016 Jan; 10(1):43-9. PubMed ID: 26449790 [TBL] [Abstract][Full Text] [Related]
18. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies. van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054 [TBL] [Abstract][Full Text] [Related]
19. Association of ZAP70 and PTPN6, but Not BANK1 or CLEC2D, with inflammatory bowel disease in the Tunisian population. Bouzid D; Fourati H; Amouri A; Marques I; Abida O; Haddouk S; Ben Ayed M; Tahri N; Penha-Gonçalves C; Masmoudi H Genet Test Mol Biomarkers; 2013 Apr; 17(4):321-6. PubMed ID: 23406209 [TBL] [Abstract][Full Text] [Related]
20. DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population. Noble CL; Nimmo ER; Drummond H; Smith L; Arnott ID; Satsangi J Gut; 2005 Oct; 54(10):1416-20. PubMed ID: 15843420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]